Emyria LtdASX: EMD

Preclinical studies initiated for MDMA-inspired analogues

· Issued by Emyria Ltd

Filed with ASX · · 4 pages · English

● Institute of Respiratory Health (IRH) engaged to conduct human cell-line studies and help advance Emyria’s MDMA-inspired drug discovery partnership with the University of Western Australia (UWA) ● IRH’s preclinical program will evaluate a set of unique MDMA-inspired analogues suggested to have “anti-fibrosis” effects, but limited neuropsychiatric action, based on early screening results ● Approva

Emyria Ltd on 6ix

Earlier from Emyria

Later from Emyria

All Emyria news releases